{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:38:34Z","timestamp":1775018314686,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010711","name":"Cancer Foundation Finland","doi-asserted-by":"publisher","award":["220002"],"award-info":[{"award-number":["220002"]}],"id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ypmed.2024.108031","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T10:38:33Z","timestamp":1717670313000},"page":"108031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lower incidence of vaginal cancer after cervical human papillomavirus screening - long-term follow-up of Finnish randomized screening trial"],"prefix":"10.1016","volume":"185","author":[{"given":"Maija","family":"Vahteristo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarit K.","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tytti","family":"Sarkeala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahti","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Hein\u00e4vaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2024.108031_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ijgo.12610","article-title":"Cancer of the vagina","volume":"143","author":"Adams","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.ypmed.2024.108031_bb0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L","article-title":"Natural history of vaginal intraepithelial neoplasia","volume":"68","author":"Aho","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0015","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ejca.2014.07.018","article-title":"Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples","volume":"50","author":"Alemany","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1471-2458-6-252","article-title":"Alternative technologies in cervical cancer screening: a randomised evaluation trial","volume":"6","author":"Anttila","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ypmed.2024.108031_bb0030","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0035","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/00365540410020677","article-title":"The prevalence of the human papillomavirus in cervix and vagina in low-risk and high-risk populations","volume":"36","author":"Baay","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2024.108031_bb0040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ygyno.2020.01.030","article-title":"Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: a population-based prospective cohort study","volume":"157","author":"Bertoli","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ypmed.2024.108031_bb0045","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1002\/ijc.33055","article-title":"Geographic and temporal variations in the incidence of vulvar and vaginal cancers","volume":"147","author":"Bray","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0050","series-title":"HPV Prevalence and Detection Sensitivity in Vaginal Intraepithelial Neoplasia: a Hospital-Based Study","author":"Chen","year":"2023"},{"key":"10.1016\/j.ypmed.2024.108031_bb0055","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/v10120729","article-title":"Cervical Cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ypmed.2024.108031_bb0060","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ypmed.2024.108031_bb0065","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-9378-3-5","article-title":"HPV type infection in different anogenital sites among HIV-positive Brazilian women","volume":"3","author":"Gon\u00e7alves","year":"2008","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0075","first-page":"F55","article-title":"Papillomavirus infections \u2014 a major cause of human cancers","volume":"1288","author":"Hausen","year":"1996","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"10.1016\/j.ypmed.2024.108031_bb0080","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12885-022-09582-5","article-title":"Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment","volume":"22","author":"Hemminki","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0085","author":"International Classification of Diseases for Oncology"},{"key":"10.1016\/j.ypmed.2024.108031_bb0090","first-page":"470","article-title":"Spontaneous regression of vulvar intraepithelial neoplasia 2-3","volume":"96","author":"Jones","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2024.108031_bb0095","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2024.108031_bb0100","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","article-title":"Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study","volume":"331","author":"Kalliala","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2024.108031_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2022-004213","volume":"33","author":"Kesic","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/LGT.0000000000000185","article-title":"A common clinical dilemma: management of abnormal vaginal cytology and human papillomavirus test results","volume":"20","author":"Khan","year":"2016","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"1\u2013150","key":"10.1016\/j.ypmed.2024.108031_bb0115","first-page":"iii","article-title":"ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening","volume":"13","author":"Kitchener","year":"2009","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ypmed.2024.108031_bb0120","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjc.6602799","article-title":"Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting","volume":"93","author":"Kotaniemi-Talonen","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2016.05.019","article-title":"Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy","volume":"142","author":"Lee","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ypmed.2024.108031_bb0130","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting","volume":"101","author":"Leinonen","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2024.108031_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2017.02.017","article-title":"Quality measures of the population-based Finnish Cancer registry indicate sound data quality for solid malignant tumours","volume":"77","author":"Leinonen","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0140","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"5","author":"Maver","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ypmed.2024.108031_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2024.108031_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijgo.13881","article-title":"Cancer of the vulva: 2021 update","volume":"155","author":"Olawaiye","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.ypmed.2024.108031_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/LGT.0000000000000683","volume":"26","author":"Preti","year":"2022","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ypmed.2024.108031_bb0160","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/aogs.14260","article-title":"The prognostic significance of HPV, p16, and p53 protein expression in vaginal cancer: a systematic review","volume":"100","author":"Rasmussen","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ypmed.2024.108031_bb0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2020.06.029","article-title":"European consensus statement on essential colposcopy","volume":"256","author":"Redman","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ypmed.2024.108031_bb0170","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1525-1438.2000.010005382.x","article-title":"Management of vaginal intraepithelial neoplasia: a series of 132 cases with long-term follow-up","volume":"10","author":"Rome","year":"2000","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0175","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1158\/1055-9965.EPI-15-1291","article-title":"Long-term risk for noncervical Anogenital Cancer in women with previously diagnosed high-grade cervical intraepithelial neoplasia: a Danish Nationwide cohort study","volume":"25","author":"Sand","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ypmed.2024.108031_bb0180","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/AOG.0000000000000171","article-title":"Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population","volume":"123","author":"Sinno","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2024.108031_bb0185","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0b013e31819bd6e0","article-title":"Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors","volume":"113","author":"Smith","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2024.108031_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2022.07.023","article-title":"Alternative cytology triage strategies for primary HPV screening","author":"Vahteristo","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ypmed.2024.108031_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2023.11.036","article-title":"Similar effectiveness with primary HPV and cytology screening - long-term follow-up of randomized cervical cancer screening trial","volume":"180","author":"Vahteristo","year":"2024","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ypmed.2024.108031_bb0200","series-title":"Human Papillomavirus and Related Diseases\u00a0: From Bench to Bedside - a Diagnostic and Preventive Perspective","year":"2013"},{"key":"10.1016\/j.ypmed.2024.108031_bb0205","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/ijc.31128","article-title":"The prevalence and concordance of human papillomavirus infection in different anogenital sites among men and women in Liuzhou, China: a population-based study","volume":"142","author":"Wei","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2024.108031_bb0210","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/14760584.2019.1692658","article-title":"Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursors","volume":"18","author":"Xu","year":"2019","journal-title":"Expert Rev. Vaccines"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743524001865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743524001865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T18:58:56Z","timestamp":1727463536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743524001865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":41,"alternative-id":["S0091743524001865"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2024.108031","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower incidence of vaginal cancer after cervical human papillomavirus screening - long-term follow-up of Finnish randomized screening trial","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2024.108031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108031"}}